Evidence map›Paper›PMID 26096534›Full record

ArticleDrug and alcohol dependence2015

"Hepatitis C treatment turned me around:" Psychological and behavioral transformation related to hepatitis C treatment.

A W Batchelder, D Peyser, S Nahvi, J H Arnsten, A H Litwin

Open access · greenAbstract read
In one paragraph

Article in Drug and alcohol dependence, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed
2.9field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

29 citing papers in PubMed, 70 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Trial
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Experiences of Hope after Treatment of Hepatitis C Infection-A Qualitative Study.International journal of environmental research and public health · 2022
    Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Observational
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

A W BatchelderEinstein-Montefiore Division of General Internal Medicine, Albert Einstein College of Medicine, 3300 Kossuth Avenue, Bronx, NY 10467, USA; Osher Center for Integrative Medicine, University of San Francisco, San Francisco, 1545 Divisadero Street, 3rd Floor, San Francisco, CA 94115, USA. Electronic address: abigail.batchelder@ucsf.edu.
D PeyserEinstein-Montefiore Division of General Internal Medicine, Albert Einstein College of Medicine, 3300 Kossuth Avenue, Bronx, NY 10467, USA; Center for Alcohol Studies, Rutgers University, 607 Allison Road, Piscataway, NJ 08854, USA. Electronic address: dpeyser@gmail.com.
S NahviEinstein-Montefiore Division of General Internal Medicine, Albert Einstein College of Medicine, 3300 Kossuth Avenue, Bronx, NY 10467, USA. Electronic address: snahvi@montefiore.org.
J H ArnstenEinstein-Montefiore Division of General Internal Medicine, Albert Einstein College of Medicine, 3300 Kossuth Avenue, Bronx, NY 10467, USA. Electronic address: jarnsten@montefiore.org.
A H LitwinEinstein-Montefiore Division of General Internal Medicine, Albert Einstein College of Medicine, 3300 Kossuth Avenue, Bronx, NY 10467, USA. Electronic address: alitwin@montefiore.org.
Albert Einstein College of Medicine · US

Funding

Special Animal CoreP30DK041296 · NIDDK · YESHIVA UNIVERSITY · PI WOLKOFF, ALLAN W · 1989 to 2018
$22.9M
Training Researchers in Clinical Integrative Medicine (TRIM) - NOSI supplementT32AT003997 · NCCIH · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI SHELLEY R ADLER, MARIA T CHAO · 2007 to 2026
$6.6M
Intensive Models of HCV Care for Injection Drug UsersR01DA034086 · NIDA · CLEMSON UNIVERSITY · PI LITWIN, ALAIN HARRIS · 2012 to 2016
$3.7M
HIV and Substance Abuse Clinical Addiction Research and Education (CARE) ProgramR25DA023021 · NIDA · ALBERT EINSTEIN COLLEGE OF MEDICINE, INC · PI ARNSTEN, JULIA H. · 2007 to 2014
$2.7M
Directly Observed Hepatitis C Treatment in Methadone ClinicsK23DA022454 · NIDA · ALBERT EINSTEIN COLLEGE OF MEDICINE · PI LITWIN, ALAIN HARRIS · 2008 to 2012
$904k
NCCIH NIH HHS T32 AT003997NCCIH NIH HHS T3AT003997NIDA NIH HHS K23DA022454NIDA NIH HHS R01 DA034086NIDA NIH HHS R01DA034086-03NIDA NIH HHS R25 DA023021NIDA NIH HHS R25DA023021NIDDK NIH HHS P30 DK041296
6 · The paper itself

Abstract

backgroundHepatitis C (HCV) is a significant public health problem that primarily affects current and former substance users. However, individuals with a history of substance use are less likely to have access to or engage in HCV care. Psychological and behavioral barriers prevent many HCV-infected individuals from initiating or engaging in HCV treatment. This study aimed to investigate the psychological and behavioral experiences of current and former substance users receiving HCV treatment within a combined methadone and primary care clinic in the United States.

methodsWe conducted 31 semi-structured qualitative interviews with opioid-dependent adults enrolled in an integrated HCV treatment program within a methadone maintenance clinic in the Bronx, NY. We used thematic analysis, informed by grounded theory, and inquired about perceptions of HCV before and after initiating HCV treatment, reasons for initiating HCV treatment, and the decision to participate in individual versus group HCV treatment.

resultsParticipants described psychological and behavioral transformation over the course of HCV treatment. These included reductions in internalized stigma and shame related to HCV and addiction, increases in HCV disclosure and self-care, reductions in substance use, and new desire to help others who are living with HCV.

conclusionsIntegrating HCV treatment with methadone maintenance has the potential to create psychological and behavioral transformations among substance using adults, including reductions in HCV- and addiction-related shame and improvements in overall self-care.

Indexed as

AdultAnalgesics, OpioidDrug UsersFemaleHepatitis CHumansMaleMethadoneMiddle AgedOpiate Substitution TreatmentSelf CareShameStereotypingSubstance Abuse, IntravenousYoung AdultAnalgesics, OpioidMethadoneHepatitis CInjection drug useInternalized stigmaMethadone maintenanceShame

Identifiers

PMID26096534
PMCPMC4759650
OpenAlexW1553237998

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.